PL375416A1 - Pochodne tiazolu - Google Patents
Pochodne tiazoluInfo
- Publication number
- PL375416A1 PL375416A1 PL03375416A PL37541603A PL375416A1 PL 375416 A1 PL375416 A1 PL 375416A1 PL 03375416 A PL03375416 A PL 03375416A PL 37541603 A PL37541603 A PL 37541603A PL 375416 A1 PL375416 A1 PL 375416A1
- Authority
- PL
- Poland
- Prior art keywords
- thiazole derivatives
- thiazole
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Child & Adolescent Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02017677 | 2002-08-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL375416A1 true PL375416A1 (pl) | 2005-11-28 |
Family
ID=31502696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL03375416A PL375416A1 (pl) | 2002-08-07 | 2003-07-31 | Pochodne tiazolu |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7253197B2 (pl) |
| EP (1) | EP1539722A1 (pl) |
| JP (1) | JP2006502131A (pl) |
| CN (1) | CN100381429C (pl) |
| AR (1) | AR040960A1 (pl) |
| AU (1) | AU2003253364B2 (pl) |
| BR (1) | BR0313278A (pl) |
| CA (1) | CA2493712A1 (pl) |
| GT (1) | GT200300167A (pl) |
| MX (1) | MXPA05001328A (pl) |
| PA (1) | PA8579301A1 (pl) |
| PL (1) | PL375416A1 (pl) |
| RU (1) | RU2324685C2 (pl) |
| TW (1) | TW200412947A (pl) |
| UY (1) | UY27930A1 (pl) |
| WO (1) | WO2004014884A1 (pl) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2006107444A (ru) | 2003-08-12 | 2007-09-20 | Ф.Хоффманн-Ля Рош Аг (Ch) | 2-амино-5-бензоилтиазолы в качестве антагонистов npy |
| WO2005058887A1 (en) * | 2003-12-08 | 2005-06-30 | F. Hoffmann-La Roche Ag | Novel thiazole derivates |
| JP4638355B2 (ja) * | 2003-12-26 | 2011-02-23 | 協和発酵キリン株式会社 | チアゾール誘導体 |
| US7652146B2 (en) * | 2004-02-06 | 2010-01-26 | Bristol-Myers Squibb Company | Process for preparing 2-aminothiazole-5-carboxamides useful as kinase inhibitors |
| AU2005236055B2 (en) * | 2004-04-20 | 2011-10-06 | Transtech Pharma, Llc | Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators |
| UA92746C2 (en) * | 2005-05-09 | 2010-12-10 | Акилайон Фармасьютикалз, Инк. | Thiazole compounds and methods of use |
| EP1894930A4 (en) | 2005-06-23 | 2010-06-23 | Kyowa Hakko Kirin Co Ltd | THIAZOLE DERIVATIVE |
| AU2006331656B2 (en) * | 2005-12-22 | 2012-08-09 | Icagen, Inc. | Calcium channel antagonists |
| US8563742B2 (en) * | 2008-08-29 | 2013-10-22 | High Point Pharmaceuticals, Llc | Substituted aminothiazole derivatives, pharmaceutical compositions, and methods of use |
| WO2010098298A1 (ja) * | 2009-02-27 | 2010-09-02 | 塩野義製薬株式会社 | 栄養素の消化吸収抑制作用を有する化合物とシクロヘキサンカルボキサミド誘導体を組み合わせてなる医薬組成物 |
| JP5610351B2 (ja) | 2009-03-10 | 2014-10-22 | 国立大学法人岐阜大学 | チアゾール誘導体およびその製造方法 |
| JP7193071B2 (ja) * | 2017-02-08 | 2022-12-20 | 国立大学法人東海国立大学機構 | 蛍光発光材料および紫外線吸収剤 |
| WO2020051424A1 (en) | 2018-09-07 | 2020-03-12 | Pic Therapeutics | Eif4e inhibitors and uses thereof |
| TW202146393A (zh) | 2020-03-03 | 2021-12-16 | 美商皮克醫療公司 | Eif4e抑制劑及其用途 |
| CN115697980B (zh) | 2020-04-24 | 2025-03-21 | 拜耳公司 | 作为dgkzeta抑制剂用于免疫活化的取代的氨基噻唑 |
| US12157732B2 (en) | 2021-08-25 | 2024-12-03 | PIC Therapeutics, Inc. | eIF4E inhibitors and uses thereof |
| CA3229560A1 (en) | 2021-08-25 | 2023-03-02 | Christopher L. Vandeusen | Eif4e inhibitors and uses thereof |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US39275A (en) * | 1863-07-21 | Machine for compressing carriage-wheels | ||
| US4035367A (en) * | 1974-09-09 | 1977-07-12 | Sandoz, Inc. | Hydroxyalkyl-substituted-amino-quinolines |
| US4308391A (en) * | 1979-10-01 | 1981-12-29 | Monsanto Company | 2-Amino-4-substituted-thiazolecarboxylic acids and their derivatives |
| US4649146A (en) * | 1983-01-31 | 1987-03-10 | Fujisawa Pharmaceutical Co., Ltd. | Thiazole derivatives and pharmaceutical composition comprising the same |
| CA1247547A (en) * | 1983-06-22 | 1988-12-28 | Paul Hadvary | Leucine derivatives |
| CA1328881C (en) | 1984-12-21 | 1994-04-26 | Pierre Barbier | Process for the manufacture of oxetanones |
| CA1270837A (en) * | 1984-12-21 | 1990-06-26 | Hoffmann-La Roche Limited | Oxetanones |
| CA2035972C (en) * | 1990-02-23 | 2006-07-11 | Martin Karpf | Process for the preparation of oxetanones |
| US5274143A (en) | 1991-07-23 | 1993-12-28 | Hoffmann-La Roche Inc. | Process for the preparation of (R)-3-hexyl-5,6-dihydro-4-hydroxy-6-undecyl-2H-pyran-2-one and (R)-5,6-dihydro-6-undecyl-2H-pyran-2,4(3H)-dione |
| US5552411A (en) | 1995-05-26 | 1996-09-03 | Warner-Lambert Company | Sulfonylquinolines as central nervous system and cardiovascular agents |
| US6004996A (en) * | 1997-02-05 | 1999-12-21 | Hoffman-La Roche Inc. | Tetrahydrolipstatin containing compositions |
| PL342447A1 (en) * | 1997-10-27 | 2001-06-04 | Agouron Pharma | Substituted 4-amino thiazol-2-yl compounds as inhibitors of cyclin-dependent kinases |
| US6267952B1 (en) | 1998-01-09 | 2001-07-31 | Geltex Pharmaceuticals, Inc. | Lipase inhibiting polymers |
| DE19824175A1 (de) * | 1998-05-29 | 1999-12-02 | Novartis Ag | Amino-azol-Verbindungen |
| WO2000009123A1 (en) | 1998-08-14 | 2000-02-24 | F. Hoffmann-La Roche Ag | Pharmaceutical compositions containing lipase inhibitors and chitosan |
| TR200100471T2 (tr) | 1998-08-14 | 2001-07-23 | F.Hoffmann-La Roche Ag | Lipaz inhibitörleri içeren farmasötik bileşimler |
| PL354784A1 (pl) | 1999-09-30 | 2004-02-23 | Neurogen Corporation | Alkileno-diamino podstawione heterocykle |
| US20010039275A1 (en) * | 2000-02-04 | 2001-11-08 | Bowler Andrew Neil | Use of 2,4-diaminothiazole derivatives |
| WO2001064675A1 (en) * | 2000-03-03 | 2001-09-07 | Novartis Ag | Condensed thiazolamines and their use as neuropeptide y5 antagonists |
| US6900226B2 (en) | 2000-09-06 | 2005-05-31 | Hoffman-La Roche Inc. | Neuropeptide Y antagonists |
| DE10064105A1 (de) * | 2000-12-21 | 2002-06-27 | Bayer Ag | Neue Substituierte Imidazotriazinone |
| JP3715280B2 (ja) | 2001-05-21 | 2005-11-09 | エフ．ホフマン−ラ ロシュ アーゲー | ニューロペプチドｙレセプターのリガンドとしてのキノリン誘導体 |
| HUP0401403A3 (en) | 2001-08-03 | 2005-11-28 | Novo Nordisk As | 2,4-diaminothiazole derivatives, their use and pharmaceutical compositions containing them |
-
2003
- 2003-07-31 RU RU2005106201/04A patent/RU2324685C2/ru not_active IP Right Cessation
- 2003-07-31 JP JP2004526832A patent/JP2006502131A/ja active Pending
- 2003-07-31 BR BR0313278-1A patent/BR0313278A/pt not_active IP Right Cessation
- 2003-07-31 CN CNB038186861A patent/CN100381429C/zh not_active Expired - Fee Related
- 2003-07-31 PL PL03375416A patent/PL375416A1/pl not_active Application Discontinuation
- 2003-07-31 WO PCT/EP2003/008473 patent/WO2004014884A1/en not_active Ceased
- 2003-07-31 EP EP03784122A patent/EP1539722A1/en not_active Withdrawn
- 2003-07-31 AU AU2003253364A patent/AU2003253364B2/en not_active Ceased
- 2003-07-31 MX MXPA05001328A patent/MXPA05001328A/es unknown
- 2003-07-31 CA CA002493712A patent/CA2493712A1/en not_active Abandoned
- 2003-08-04 PA PA20038579301A patent/PA8579301A1/es unknown
- 2003-08-04 TW TW092121281A patent/TW200412947A/zh unknown
- 2003-08-05 UY UY27930A patent/UY27930A1/es not_active Application Discontinuation
- 2003-08-05 US US10/634,431 patent/US7253197B2/en not_active Expired - Fee Related
- 2003-08-05 GT GT200300167A patent/GT200300167A/es unknown
- 2003-08-05 AR ARP030102807A patent/AR040960A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2005106201A (ru) | 2006-11-20 |
| WO2004014884A1 (en) | 2004-02-19 |
| AU2003253364B2 (en) | 2007-06-07 |
| RU2324685C2 (ru) | 2008-05-20 |
| EP1539722A1 (en) | 2005-06-15 |
| TW200412947A (en) | 2004-08-01 |
| CA2493712A1 (en) | 2004-02-19 |
| PA8579301A1 (es) | 2004-05-26 |
| CN1675188A (zh) | 2005-09-28 |
| AR040960A1 (es) | 2005-04-27 |
| BR0313278A (pt) | 2005-07-05 |
| US20040038990A1 (en) | 2004-02-26 |
| CN100381429C (zh) | 2008-04-16 |
| MXPA05001328A (es) | 2005-04-28 |
| GT200300167A (es) | 2004-03-16 |
| US7253197B2 (en) | 2007-08-07 |
| JP2006502131A (ja) | 2006-01-19 |
| UY27930A1 (es) | 2003-12-31 |
| AU2003253364A1 (en) | 2004-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL372123A1 (pl) | Pochodne tiazolu | |
| PL3002283T3 (pl) | Pochodne tiazolu | |
| AP1850A (en) | Spiroindolineplperidine derivatives | |
| EG24050A (en) | Heterocylocarboxamide derivatives | |
| PL374718A1 (pl) | Azolidynono-winylowe pochodne skondensowanego benzenu | |
| IL166121A0 (en) | Indole-3-sulphur derivatives | |
| EP1522540A4 (en) | AZAARENE DERIVATIVES | |
| PL376475A1 (pl) | Pochodne N-podstawionej 2-oksodihydropirydyny | |
| AU2003302763A8 (en) | Insecticidal aminothiazole derivatives | |
| IL161623A0 (en) | Nicotin-or isonicotin benzothiazole derivatives | |
| PL370978A1 (pl) | Pochodne benzotiazolu | |
| IL166426A0 (en) | N-biarylmethyl aminocycloalkanecarboxamide derivatives | |
| GB0315870D0 (en) | Heterocyclic derivatives | |
| PL375416A1 (pl) | Pochodne tiazolu | |
| AU2003222659A8 (en) | 23-o-substituted 5-o-mycaminosyltylonide derivatives | |
| AU2003294938A8 (en) | Epothilone derivatives | |
| PL373947A1 (pl) | Pochodne benzotiazolu | |
| EP1531854A4 (en) | O-DERIVATED NOCATHIACIN DERIVATIVES | |
| GB0213488D0 (en) | 2-Naphthamide derivatives | |
| AU2003243397A8 (en) | Homo-camptothecin derivatives | |
| GB0220962D0 (en) | Heterocyclic derivatives | |
| GB0311957D0 (en) | Heterocyclic derivatives | |
| AU2003285777A8 (en) | 3-substituted-4-pyrimidone derivatives | |
| GB0210512D0 (en) | Tetrahydro-napthalene derivatives | |
| GB0219894D0 (en) | Dihydropyridinone derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |